PET/MR中正常脊髓的[18F]FDG摄取:与PET/CT的比较
本研究回顾性纳入41例无脊髓或骨髓受累的淋巴瘤患者,在同机PET/MRI上测量正常脊髓的[18F]FDG摄取,并与PET/CT比较。结果显示PET/MRI脊髓SUVmax和SUVmean与PET/CT相似,但经肝脏归一化的NSUVmax和NSUVmean在PET/MRI中更高(范围21-47%)。
要点
- PET/MRI可精确勾画脊髓,测得正常脊髓[18F]FDG摄取的纵向分布。
- 脊髓SUVmax和SUVmean在PET/MRI与PET/CT间相似。
- 脊髓NSUVmax和NSUVmean在PET/MRI中较PET/CT高21-47%。
核心结论
- 采用全身协议定义了PET/MRI中正常脊髓的最大和平均[18F]FDG摄取。
- PET/MRI测得的脊髓摄取呈预期纵向分布,但归一化值高于PET/CT。
- 将脊髓SUVmax和SUVmean归一化至肝脏摄取有助于多中心比较和研究。
研究设计与样本
- 回顾性研究纳入41例无脊髓或骨髓受累临床或MRI征象的淋巴瘤患者。
- 注射3.5 MBq/kg体重的[18F]FDG后行同步PET/MRI(Siemens Biograph mMR)采集。
- 在C2、C5、T6、T12和L3五个层面的脊髓、腰段脑脊液和椎体骨髓放置直径3 mm和9 mm的ROI。
- 测量SUVmax、SUVmean及经肝脏归一化的NSUVmax和NSUVmean。
- 在PET/MRI采集前即刻行PET/CT,以相同ROI进行比较。
主要发现
- 3 mm ROI时,脊髓(除L3外所有层面)SUVmean中位数(1st和3rd四分位)为1.68(1.39和1.83)。
- 3 mm ROI时,脊髓SUVmax中位数为1.92(1.60和2.14)。
- 3 mm ROI时,脊髓NSUVmean中位数为1.18(0.93和1.36),NSUVmax中位数为1.27(1.01和1.33)。
- 9 mm ROI时,脊髓SUVmean中位数为1.41(1.25-1.55),SUVmax中位数为2.41(2.08和2.61)。
- 9 mm ROI时,脊髓NSUVmean中位数为0.93(0.79和1.04),NSUVmax中位数为1.28(1.02和1.39)。
关键数值与推荐
- 3 mm ROI时,PET-MRI的SUVmax、SUVmean、NSUVmax和NSUVmean最高值一致见于C5,最低值见于T6。
- 9 mm ROI时,最高值一致见于C5,最低值见于T12或T6。
- 脊髓[18F]FDG摄取值与同层面骨髓摄取相关,尤其在NSUVmax时。
- PET-MRI与PET-CT的脊髓平均SUVmax和SUVmean相似。
- PET-MRI的脊髓平均NSUVmax和NSUVmean较PET-CT高(范围21-47%)。
临床怎么用
- PET/MRI中评估正常脊髓[18F]FDG摄取可参考本研究定义的SUVmax和SUVmean值。
- 经肝脏归一化的NSUVmax和NSUVmean可能有助于多中心比较和研究。
- 需注意PET/MRI中脊髓归一化摄取值高于PET/CT。
局限性
- 回顾性研究,样本量41例。
- 仅纳入无脊髓或骨髓受累的淋巴瘤患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The lack of visualization of the spinal cord hinders the evaluation of [18F]Fluoro-deoxy-glucose (FDG) uptake of the spinal cord in PET/CT. By exploiting the capability of MRI to precisely outline the spinal cord, we performed a retrospective study aimed to define normal pattern of spinal cord [18F]FDG uptake in PET/MRI. METHODS: Forty-one patients with lymphoma without clinical or MRI signs of spinal cord or bone marrow involvement underwent simultaneous PET and MRI acquisition using Siemens Biograph mMR after injection of 3.5 MBq/kg body weight of [18F]FDG for staging purposes. Using a custom-made software, we placed ROIs of 3 and 9 mm in diameter in the spinal cord, lumbar CSF, and vertebral marrow that were identified on MRI at 5 levels (C2, C5, T6, T12, and L3). The SUVmax, SUVmean, and the SUVmax and SUVmean normalized (NSUVmax and NSUVmean) to the liver were measured. For comparison, the same ROIs were placed in PET-CT images obtained immediately before the PET-MRI acquisition following the same tracer injection. RESULTS: On PET/MRI using the 3 mm ROI, the following average (all level excluding L3) spinal cord median (1st and 3rd quartile) values were measured: SUVmean, 1.68 (1.39 and 1.83); SUVmax, 1.92 (1.60 and 2.14); NSUVmean, 1.18 (0.93 and 1.36); and NSUVmax, 1.27 (1.01 and 1.33). Using the 9 mm ROI, the corresponding values were SUVmean, 1.41 (1.25-1.55); SUVmax, 2.41 (2.08 and 2.61); NSUVmean, 0.93 (0.79 and 1.04); and NSUVmax, 1.28 (1.02 and 1.39). Using the 3 mm ROI, the highest values of PET-MRI SUVmax, SUVmean, NSUVmax, and NSUVmean were consistently observed at C5 and the lowest at T6. Using a 9 mm ROI, the highest values were consistently observed at C5 and the lowest at T12 or T6. The spinal cord [18F]FDG-uptake values correlated with the bone marrow uptake at the same level, especially in case of NSUVmax. Comparison with PET-CT data revealed that the average SUVmax and SUVmean of the spinal cord were similar in PET-MRI and PET-CT. However, the average NSUVmax and NSUVmean of the spinal cord were higher (range 21-47%) in PET-MRI than in PET-CT. CONCLUSIONS: Using a whole-body protocol, we defined the maximum and mean [18F]FDG uptake of the normal spinal cord in PET/MRI. While the observed values show the expected longitudinal distribution, they appear to be higher than those measured in PET/CT. Normalization of the SUVmax and SUVmean of the spinal cord to the liver radiotracer uptake could help in multi-institutional comparisons and studies.
引用
- Aiello M, Alfano V, Salvatore E, et al. [18F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging. EJNMMI Res. 2020. PMID: 32761394. doi:10.1186/s13550-020-00680-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。